Em Canh Pham

Em Canh Pham

Auto-generated profile, based on publicly available information

Em Canh Pham

Faculty of Pharmacy, Hong Bang International University, 700000 Ho Chi Minh City, Viet Nam

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
LVLenh Vo Van
Lenh Vo Van
EPEm Canh Pham
Em Canh Pham
CNCuong Viet Nguyen
Cuong Viet Nguyen
NDNgoc Thoi Nguyen Duong
Ngoc Thoi Nguyen Duong
TTTuong Vi Le Thi
Tuong Vi Le Thi
TTTuyen Ngoc Truong
Tuyen Ngoc Truong
The antidiabetic activity of stem-ethanol extract (SE) and the flavonoid-rich fraction (FF) of Merremia tridentata (L.) were investigated on alloxan-induced diabetic mice. Apigenin, cosmosiin, and quercitrin are flavonoids isolated for the first time from stem extracts. In addition, cynaroside was found to be at the highest level in SE and FF with a percentage of 4.375% and 58.430%, respectively. The administration of SE (100 mg/kg) and FF (50, 75 mg/kg) daily for 20 days resulted in a better hypoglycemic effect than the reference drugs, glibenclamide (5 mg/kg), and metformin (10 mg/kg). Furthermore, SE and FF were shown to significantly improve the plasma lipid profiles at the end of the study. Docking's study suggests that cynaroside, cosmosiin, and quercitrin are the most desirable compounds for hypoglycemic effects in many antidiabetic targets. Especially, SE and FF showed strongly α-amylase and α-glucosidase inhibitory activities (IC50 = 1.61-1.72 mg/mL on α-amylase and IC50 = 0.24-0.44 mg/mL on α-glucosidase). Therefore, SE and FF of Merremia tridentata is a potential drug with antidiabetic and hypoglycemic action as indicated by in vivo, in silico, and in vitro studies.

1 May 2022 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EPEm Canh Pham
Em Canh Pham
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
NDNguyen Hanh Dong
Nguyen Hanh Dong
DVDuy Duc Vo
Duy Duc Vo
TDTuoi Thi Hong Do
Tuoi Thi Hong Do
Background: Many compounds containing a five-membered heterocyclic ring display exceptional chemical properties and versatile biological activities. Objective: The objective of the present study was to prepare the 5-substituted 2-amino-1,3,4- oxadiazole and 2-amino-1,3,4-thiadiazole derivatives and evaluate their potential anticancer, antibacterial and antifungal activities. Methods: Twenty-seven derivatives were synthesized by iodine-mediated cyclization of semicarbazones or thiosemicarbazones obtained from condensation of semicarbazide or thiosemicarbazide and aldehydes. The structures were confirmed by 1H-NMR, 13C-NMR and MS spectra. The antibacterial and antifungal activities were evaluated by diffusion method and the anticancer activities were evaluated by MTT assay. Results: Twenty-seven derivatives have been synthesized in moderate to good yields. A number of derivatives exhibited potential antibacterial, antifungal and anticancer activities. Conclusion: Compounds (1b, 1e and 1g) showed antibacterial activity against Streptococcus faecalis, MSSA and MRSA with MIC value ranging between 4 to 64 μg/mL. Compound (2g) showed antifungal activity against Candida albicans (8 μg/mL) and Aspergillus niger (64 μg/mL). Compound (1o) exhibited high cytotoxic activity against HepG2 cell line (IC50 value 8.6 μM) which is comparable to the activity of paclitaxel, and is non-toxic on LLC-PK1 normal cell line. The structure activity relationship and molecular docking study of the synthesized compounds have also been reported.

19 December 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
EPEm Canh Pham
Em Canh Pham
TTTuong Vi Le Thi
Tuong Vi Le Thi
HHHuong Ha Ly Hong
Huong Ha Ly Hong
BTBich Ngoc Vo Thi
Bich Ngoc Vo Thi
LVLong Binh VONG
Long Binh VONG
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
The purpose of this study is to synthesize novel N ,2,6-trisubstituted 1 H -benzimidazole derivatives and evaluation of their antibacterial, antifungal, and anticancer activities as well as to study their mechanism of action.

21 July 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
EPEm Canh Pham
Em Canh Pham
TLTuong Vi Thi Le
Tuong Vi Thi Le
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
The purpose of this study is to synthesize novel N-substituted 6-(chloro/nitro)-1H-benzimidazole derivatives with various substituted aryl groups at position 2 and alkylation at position 1, and evaluate their antimicrobial and anticancer activities.

1 February 2016 in Tetrahedron Letters
Verified
Journal Article
Closed access
HBHue Thi Buu Bui
Hue Thi Buu Bui
QHQuy Thi Kim Ha
Quy Thi Kim Ha
WOWon Keun Oh
Won Keun Oh
DVDuy Duc Vo
Duy Duc Vo
YCYen Nguyen Tram Chau
Yen Nguyen Tram Chau
VMVan-Hieu Mai
Van-Hieu Mai

9 September 2022 in ACS Omega
Verified
Journal Article
Open access
EPEm Canh Pham
Em Canh Pham
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
Naphthamide is a common structural framework with diverse pharmacological activities. Ten novel 2-naphthamide derivatives have been designed, synthesized, and evaluated for their in vitro antibacterial, antifungal, and anticancer activities. The title compounds were synthesized from dimethoxybenzaldehyde derivatives through a four-step microwave-assisted synthesis process. The structures were confirmed by 1H NMR, 13C NMR, and MS spectra. Compound 8b showed good antibacterial activity against Escherichia coli, Streptococcus faecalis, Salmonella enterica, MSSA, and MRSA with MIC values of 16, 16, 16, 8, and 16 μg/mL, respectively, compared to ciprofloxacin (MIC = 8-16 μg/mL). Compounds 5b (IC50 = 3.59-8.38 μM) and 8b (IC50 = 2.97-7.12 μM) exhibited good cytotoxic activity against C26, HepG2, and MCF7 cancer cell lines as compared to paclitaxel (IC50 = 2.85-5.75 μM). Moreover, compounds 5b and 8b exhibited better anticancer activity than PTX against the C26 cell line. In particular, compound 8b showed potent in vitro VEGFR-2 inhibitory activity with the IC50 value of 0.384 μM compared with sorafenib (IC50 = 0.069 μM). Therefore, compound 8b is the most potent compound for anticancer activity as indicated by in vitro cell line inhibition, in silico ADMET, molecular docking, and in vitro VEGFR-2 inhibition studies.